Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.61 |
| ▸ | MIF | P14174 | 1/20 | 0.61 |
| ▸ | TYR | P14679 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.54 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6510666 | 0.90 | ALDH1A1 (0.67) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL1764594 | 0.85 | ALDH1A1 (0.45) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL15956741 | 0.84 | ALOX15 (0.48) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL2788496 | 0.84 | ALDH1A1 (0.53) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL30390153 | 0.82 | ALOX15 (0.54) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL6044777 | 0.82 | ALOX15 (0.54) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL6452950 | 0.79 | ALOX15 (0.43) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL30874683 | 0.78 | PTGDR2 (0.46) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL9248443 | 0.78 | PTGDR2 (0.46) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA | |
| SCHEMBL6153419 | 0.78 | ALOX15 (0.42) | ALDH1A1ALOX15CYP2C9HSD17B10LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-114195624-B | Preparation method of butyl hydroxyanisole | 广东东阳光药业股份有限公司 | 2025-02-11 | — | — | CN | claimed |
| CN-119350639-A | Micron-scale stable trimetallic MOF oxygen evolution catalyst and preparation method and application thereof | 浙江工业大学 | 2025-01-24 | — | — | CN | claimed |
| CN-114195624-A | Preparation method of butyl hydroxy anisole | 广东东阳光药业有限公司 | 2022-03-18 | — | — | CN | claimed |
| CN-113966739-A | Dinotefuran granules and production process thereof | 广西乐土生物科技有限公司 | 2022-01-25 | — | — | CN | claimed |
| CN-113956098-A | Method for preventing and treating sugarcane borers | 广西乐土生物科技有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113698246-A | Method for preventing and treating sugarcane borers | 广西乐土生物科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| CN-1745198-A | Method of preparing brominated hydroxy aromatic compounds | GEN ELECTRIC (US) | 2006-03-08 | — | — | CN | claimed |
| US-6827836-B2 | With high para selectivity; hydrogen bromide not generated as a by-product; | GENERAL ELECTRIC COMPANY | 2004-12-07 | — | — | US | claimed |
| WO-2004050954-A1 | METHOD OF PREPARING BROMINATED HYDROXY AROMATIC COMPOUNDS | GENERAL ELECTRIC COMPANY (US) | 2004-06-17 | — | — | WO | claimed |
| US-20040104126-A1 | Method of preparing brominated hydroxy aromatic compounds | GENERAL ELECTRIC COMPANY | 2004-06-03 | — | — | US | claimed |
| US-4898993-A | Process for preparing 2-tert-butyl-4-methoxyphenol | BROMINE COMPOUNDS LIMITED (IL) | 1990-02-06 | — | — | US | claimed |
| CN-122037020-A | Supported catalyst, preparation method thereof and application thereof in olefin polymerization | 中国石油化工股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260078136-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR | PROTEOSTASIS THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20250163038-A1 | CBL-B MODULATORS AND USES THEREOF | NIMBUS CLIO, INC. | 2025-05-22 | — | — | US | disclosed |
| EP-0679628-A1 | Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1995-11-02 | — | — | EP | disclosed |
| EP-0661258-A1 | Biaromatic propynyl compounds, pharmaceutical compositions and cosmetics containing them and their uses | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA, ( CIRD GALDERMA) (FR) | 1995-07-05 | — | — | EP | disclosed |
| US-4898993-A | Process for preparing 2-tert-butyl-4-methoxyphenol | BROMINE COMPOUNDS LIMITED (IL) | 1990-02-06 | — | — | US | disclosed |
| US-4898993-A | Process for preparing 2-tert-butyl-4-methoxyphenol | BROMINE COMPOUNDS LIMITED (IL) | 1990-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250163038-A1 | CBL-B MODULATORS AND USES THEREOF | CBLB, CBL, CBLC | ALDH1A1 4185/4885ALOX15 3000/4885CYP2C9 4713/4885 |
| US-20260078136-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR | CFTR, SCNN1B, SCNN1A | ALDH1A1 2383/4885ALOX15 4473/4885CYP2C9 1034/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | ALDH1A1 100/4885ALOX15 922/4885CYP2C9 271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.